Next Financial Group’s NovoCure NVCR Stock Holding History

Next Financial Group’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$0	Buy	4 +1	+33%	+$100	﹤0.01%	2932
2021 Q3	$0	Buy	+3	New	+$454	﹤0.01%	2795
2021 Q1	–	Sell	-200	Closed	-$35K	–	2607
2020 Q4	$35K	Buy	+200	New	+$27.4K	﹤0.01%	1319
2020 Q1	–	Sell	-122	Closed	-$10K	–	2319
2019 Q4	$10K	Sell	122 -1,839	-94%	-$148K	﹤0.01%	1775
2019 Q3	$146K	Buy	1,961 +1,861	+1,861%	+$149K	0.02%	786
2019 Q2	$6K	Hold	100	–	–	﹤0.01%	1842
2019 Q1	$5K	Hold	100	–	–	﹤0.01%	1265
2018 Q4	$3K	Hold	100	–	–	﹤0.01%	1685
2018 Q3	$5K	Buy	+100	New	+$3.98K	﹤0.01%	1163

Other funds holding NVCR

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Next Financial Group's NVCR Position: Q4 2021 in Review

Next Financial Group increased its NovoCure (NVCR) stake by 33% in Q4 2021, buying an estimated $100 and bringing the position to 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Next Financial Group first reported a position in NVCR in Q3 2018 and has held it in 9 quarters since. The position peaked at $146K in Q3 2019. 311 funds tracked by Wall St. Rank hold NVCR as of Q4 2021.

Next Financial Group held 4 shares of NovoCure worth $0 as of Q4 2021.
Next Financial Group bought 1 NovoCure share in Q4 2021, an estimated $100.
NovoCure made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2932 holding.
Next Financial Group first reported a position in NovoCure in Q3 2018 and has held it in 9 quarters since.
Next Financial Group's NovoCure position peaked at $146K in Q3 2019.
311 funds tracked by Wall St. Rank held NovoCure as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.